|
Mitochondrials |
Low level laser irradiation
stimulates mitochondrial membrane potential and
disperses subnuclear promyelocytic leukemia protein.
Gavish L; Asher Y; Becker Y; Kleinman Y
Lasers in surgery and medicine; VOL: 35 (5);
p. 369-76 /2004/
Department of Molecular Virology, The Faculty of
Medicine, The Hebrew University of Jerusalem,
Jerusalem, Israel.
lilach_g@md.huji.ac.il
BACKGROUND AND OBJECTIVES: Low level laser
irradiation (LLLI) is used to promote wound healing.
Molecularly it is known to stimulate mitochondrial
membrane potential (MMP), cytokine secretion, and
cell proliferation. This study was designed to
determine the influence of LLLI on the kinetics of
MMP stimulation and decay, specific cytokine gene
expression, and subcellular localization of
promyelocytic leukemia (PML) protein on HaCaT human
keratinocytes. STUDY DESIGN/MATERIAL AND METHODS:
The cells were irradiated by a 780 nm
titanium-sapphire (Ti-Sa) laser with 2 J/cm(2)
energy density. MMP was monitored with Mitotracker,
a mitochondrial voltage-sensitive fluorescent dye.
Cytokine gene expression was carried out using
semi-quantitative-reverse transcription polymerase
chain reaction. Subcellular localization of PML
protein, a cell-cycle checkpoint protein, was
determined using immunofluorescent staining.
RESULTS: The fluorescence intensity of MMP was
increased immediately after the end of LLLI by 148
+/- 6% over control (P<0.001). Subsequently it
decayed, reaching 51 +/- 14% of the control level (P
< 0.01) within 200 minutes. This decay was
characterized by an exponential curve (R = 0.96)
with a lifetime of 79 +/- 36 minutes (P < 0.05).
Following irradiation, the expression of
interleukin-1alpha, interleukin-6, and keratinocyte
growth factor (KGF) genes were transiently
upregulated; but the expression of the
proinflammatory gene interleukin-1beta, was
suppressed. The subnuclear distribution of PML was
altered from discrete domains to its dispersed form
within less than 1 hour after LLLI.
CONCLUSIONS: These changes reflect a biostimulative
boost that causes a shift of the cell from a
quiescent to an activated stage in the cell cycle
heralding proliferation and suppression of
inflammation. Further characterization of MMP
kinetics may provide a quantitative basis for
assessment of the effect of LLLI in the clinical
setting. - CNOTE: (c) 2004 Wiley-Liss, Inc.
|